# NEUROGENE INC (NGNE)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/NGNE/

- Reporting holders: 4
- Reported value: $24.1K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $18.1K | 650 | 0.0% | 8 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $4.5K | 161 | 0.0% | 3 |
| [EASTERN BANK](https://holderbook.com/funds/1126395-eastern-bank/) | $1.4K | 50 | 0.0% | 1 |
| [CoreCap Advisors, LLC](https://holderbook.com/funds/1902501-corecap-advisors-llc/) | $111 | 4 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $24.1K |
| Q2 2026 | 116 | $570.5M |
| Q1 2026 | 99 | $346.3M |
| Q4 2025 | 95 | $340.6M |
| Q3 2025 | 90 | $267.5M |
| Q2 2025 | 85 | $232.3M |
| Q1 2025 | 87 | $196.9M |
| Q4 2024 | 92 | $376.4M |
| Q3 2024 | 86 | $581.3M |
| Q2 2024 | 66 | $485.5M |
| Q1 2024 | 59 | $669.9M |
| Q4 2023 | 35 | $186.9M |